Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Eur J Cancer Care (Engl) ; 22(6): 797-806, 2013 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-23834290

RESUMEN

Informal carers provide important emotional support to patients having chemotherapy and assistance in monitoring and managing side-effects. If they are inadequately supported in this, patient and carer morbidity may result. This study explored needs of informal carers supporting patients with cancer having chemotherapy. The study used a mixed methods approach. Carers of colorectal or lymphoma cancer patients at one comprehensive cancer centre participated. Questionnaire data informed semi-structured interviews conducted with a subsample of respondents. Interviews were analysed using Framework analysis. Questionnaire data were analysed descriptively. Fifty-nine informal carers were invited to participate; 48 returned the questionnaire (response rate 81%) and 13 were interviewed. Informal carers' needs for information about chemotherapy and its side-effects were largely met although a third felt completely or somewhat unprepared to deal with particular symptoms experienced by patients at home. Many carers had unmet needs regarding financial support and their own needs as carers. Assertiveness was important to many caring roles, but it appeared difficult for informal carers to adopt when they were unsupported in this and their role was unrecognised by health professionals. Future research should develop interventions to systematically prepare carers for their carer role, improve carer involvement and ultimately improve patient outcomes.


Asunto(s)
Antineoplásicos/uso terapéutico , Cuidadores , Necesidades y Demandas de Servicios de Salud , Atención Domiciliaria de Salud/psicología , Neoplasias/enfermería , Apoyo Social , Adulto , Anciano , Anciano de 80 o más Años , Cuidadores/psicología , Femenino , Humanos , Londres , Masculino , Persona de Mediana Edad , Neoplasias/tratamiento farmacológico , Neoplasias/psicología , Encuestas y Cuestionarios
2.
Psychopharmacology (Berl) ; 156(2-3): 177-81, 2001 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-11549220

RESUMEN

RATIONALE: Repeated administration of psychoactive drugs results in a progressive enhancement of the behavioral effects of these compounds, a phenomenon termed sensitization. OBJECTIVE: We tested whether repeated administration of the non-competitive NMDA receptor antagonist dizocilpine (MK-801) induces sensitization of the disruptive effects of this compound on prepulse inhibition (PPI) of startle. METHODS: Rats received nine daily i.p. injections of 0.1 mg/kg MK-801 in the startle cage and were tested for PPI, startle in the absence of prepulses and motor activity in the startle cage. Another group of rats received MK-801 in the home cage on 9 days without daily testing. Controls were injected with saline and tested daily, while a separate group of rats received saline in the home cage without daily testing. On day 10, all rats received saline injections and were tested. On day 11, all rats were injected with 0.1 mg/kg MK-801 and tested again. On day 12, all rats received 1 mg/kg dl-amphetamine i.p. and were tested for PPI, to assess a possible cross-sensitization. RESULTS: MK-801 had no effect on day 1 of testing but induced a PPI deficit after 6-9 days of daily treatment and testing in those rats that received the drug in the startle cage, but not in the home cage. Motor activity was increased after repeated treatment and testing. There was also a trend towards sensitization of enhancement of the startle magnitude by MK-801 in these rats. dl-Amphetamine reduced PPI in those rats that received daily MK-801 injections in the startle cage to a similar extent as saline injections. CONCLUSIONS: Since PPI is considered as a measure of sensorimotor gating, our data indicate that sensorimotor gating deficits induced by MK-801 are subject to a sensitization process. These findings may be relevant for current hypotheses relating schizophrenic symptoms to sensitization.


Asunto(s)
Maleato de Dizocilpina/farmacología , Antagonistas de Aminoácidos Excitadores/farmacología , Reflejo de Sobresalto/efectos de los fármacos , Estimulación Acústica , Anfetamina/farmacología , Animales , Dopamina/fisiología , Inhibidores de Captación de Dopamina/farmacología , Relación Dosis-Respuesta a Droga , Masculino , Actividad Motora/efectos de los fármacos , Ratas , Ratas Sprague-Dawley
3.
Scand J Gastroenterol ; 21(5): 556-8, 1986 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-3749795

RESUMEN

Because of the increasing and repeated application of colonoscopy and double-contrast barium enema with the Welin modification in connection with the checking of patients who have been treated for neoplastic polyps, we have found it valuable to examine the amount of radiation that the patients are exposed to in the two kinds of examinations. The radiation dose in the examination of the colon with the Welin modification (35 examinations) and at colonoscopy (114 examinations) was, on an average, 387 and 10 mSv, respectively. Since colonoscopy gives a possibility not only of diagnosis but also of treatment and also exposes the patients to 40 times less radiation than X-ray examination with the Welin modification, we recommend colonoscopy for diagnosis and treatment of neoplastic colonic polyps.


Asunto(s)
Sulfato de Bario , Colon/diagnóstico por imagen , Pólipos del Colon/diagnóstico , Colonoscopía/métodos , Adolescente , Adulto , Anciano , Neoplasias del Colon/diagnóstico por imagen , Neoplasias del Colon/etiología , Enema , Femenino , Humanos , Masculino , Persona de Mediana Edad , Neoplasias Inducidas por Radiación/etiología , Dosis de Radiación , Radiografía , Riesgo
4.
Scand J Gastroenterol ; 21(3): 353-6, 1986 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-3715399

RESUMEN

In this study the predictive value of a negative double-contrast barium enema for colonic polyps has been calculated as the ratio of the number of true negative radiologic examinations to the total number of negative radiologic examinations. The total number of negative double-contrast barium enemas for polyps of the colon was 357 in 228 consecutive patients with previous or suspected neoplastic colonic polyps examined in the period 1977-84. The predictive value of a negative double-contrast barium enema for all colonic polyps regardless of size was 87% (95% confidence interval, 84-91%). The corresponding predictive value of a negative result for polyps larger than 10 mm in diameter was 98% (95% confidence interval, 97-100%). Polyps that had not been detected by radiography were removed by colonoscopy, and 85% of them were available for histological examination. No cancers were found. The polyps were primarily neoplastic, but metaplastic and juvenile polyps were also ascertained.


Asunto(s)
Sulfato de Bario , Pólipos del Colon/diagnóstico por imagen , Adolescente , Adulto , Anciano , Niño , Pólipos del Colon/cirugía , Enema , Estudios de Seguimiento , Humanos , Persona de Mediana Edad , Pronóstico , Radiografía
6.
Acta Pharmacol Toxicol (Copenh) ; 40(4): 482-90, 1977 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-577108

RESUMEN

The duration and intensity of the neuroleptic effect of cis(Z)-clopenthixol decanoate in Viscoleo have been compared with those of cis(Z)-clopenthixol, 2 HCl in aqueous solution in a number of animal experimental models. Cis(Z)-clopenthixol, 2 HCl had a strong, but short-lasting neuroleptic effect (apomorphine antagonistic effect in dogs, inhibition of conditioned avoidance response in rats) which was accompanied by marked sedation. In contrast, cis(Z)-clopenthixol decanoate in oil had an effect which was slower in onset, but of much longer duration and only the highest doses caused a slight sedation. In rats catalepsy could be induced in some animals by high doses of cis(Z)-clopenthixol decanoate whereas cis(Z)-clopenthixol, 2 HCl at all the doses tested caused catalepsy in all animals. In mice only high doses of cis(Z)-clopenthixol decanoate in oil caused reduction of spontaneous motor activity and potentiation of barbiturate anaesthesia. The results are discussed with special reference to the clinical use of the depot preparation.


Asunto(s)
Conducta Animal/efectos de los fármacos , Clopentixol/administración & dosificación , Tioxantenos/administración & dosificación , Administración Oral , Animales , Apomorfina/antagonistas & inhibidores , Apomorfina/farmacología , Barbitúricos/farmacología , Catalepsia , Clopentixol/antagonistas & inhibidores , Clopentixol/farmacología , Preparaciones de Acción Retardada , Perros , Relación Dosis-Respuesta a Droga , Evaluación Preclínica de Medicamentos , Sinergismo Farmacológico , Reacción de Fuga/efectos de los fármacos , Femenino , Humanos , Inyecciones Subcutáneas , Masculino , Ratones , Actividad Motora/efectos de los fármacos , Ratas , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA